6 results
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
to such laws, including all laws and regulations applicable to ownership, testing, development, manufacture, packaging, processing, use, distribution
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
materials needed for use in clinical trials and preclinical trials;
- 17 -
obtaining adequate materials for packaging clinical trial material … candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
in clinical trials and preclinical trials;
- 17 -
obtaining adequate materials for packaging clinical trial material;
expiration of the shelf life … or a comparable foreign regulatory authority approves MLS-101 or any future product candidates, the manufacturing processes, labeling, packaging
DRS
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
or other materials needed for use in clinical trials and preclinical trials;
obtaining adequate materials for packaging clinical trial material … , packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping for our products will be subject
DRS
EX-10.9
sw3pgzoi4rsjy qi
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next